Effect of 8-hydroxy-2-(N,N-di-n-propylamino)tetralin and MDMA on the discriminative stimulus effects of the classical hallucinogen DOM in rats

被引:8
作者
Khorana, Nantaka [1 ]
Young, Richard [1 ]
Glennon, Richard A. [1 ]
机构
[1] Virginia Commonwealth Univ, Sch Pharm, Dept Med Chem, Richmond, VA 23298 USA
关键词
DOM; MDMA; (+/-)8-OH DPAT; R(+)8-OH DPAT; S(-)8-OH DPAT; NAN-190; Methylenedioxymethamphetamine; Hallucinogens; Drug discrimination; 5-HT1A RECEPTOR; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; SEROTONIN; AGONIST; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; BINDING; ECSTASY; PHARMACOLOGY; ENANTIOMERS; HYPOTHERMIA;
D O I
10.1016/j.pbb.2008.08.013
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Co-administration of the 5-HT1A serotonin receptor agonist (+/-)8-hydroxy-2-(N.N-di-n-propylamino)tetralin [(+/-)8-OH DPAT] enhances the discriminative stimulus effects of the classical hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in rats. In the present investigation, using Sprague-Dawley rats trained to discriminate DOM (1.0 mg/kg) from saline Vehicle Lindera VI-15 s schedule of reinforcement it was, shown that the stimulus-enhancing actions of 8-OH DPAT are related more to its R(+)-isomer than to its S(-)enantiomer, and that the (+/-)- and R(+)8-OH DPAT-induced effects are antagonized by the 5-HT1A receptor antagonist NAN-190. (+/-)8-OH DPAT and its isomers substitute in rats trained to discriminate the designer drug N-methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA; methylenedioxymethamphetamine) from vehicle indicating some similarity of effect. On this basis, it was hypothesized that MDMA might be capable of enhancing the DOM stimulus. Co-administration of MDMA with low (i.e., 0.1 and 0.3 mg/kg) doses of DOM resulted in greater DOM-appropriate responding than engendered by administration of DOM alone. As such, the present findings are the first to demonstrate an MDMA-induced enhancing effect on the discriminative stimulus actions of a classical hallucinogen. The results also Suggest that a 5-HT1A serotonin receptor mechanism might contribute to this phenomenon. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:385 / 392
页数:8
相关论文
共 34 条
[21]   DIFFERENTIAL CARDIOVASCULAR EFFECTS OF 8-HYDROXY-2-(DI-N-PROPYLAMINO) TETRALIN (8-OH-DPAT), FLESINOXAN, 5-METHYL-URAPIDIL AND MDL-75,608A IN CONSCIOUS SPONTANEOUSLY HYPERTENSIVE RATS [J].
BUISSONDEFFERIER, S ;
HIBERT, M ;
VANDENBUUSE, M .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1993, 7 (09) :499-511
[22]   Attenuation of Somatodendritic Responses to 8-Hydroxy-2-Di-N-Propylamino Tetralin Following Long-Term Dietary Sugar Consumption in Rats [J].
Inam, Qurrat-ul-Aen ;
Haleen, M. Abdul ;
Haleem, Darakhshan Labeen .
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2009, 19 (07) :401-405
[23]   8-[3H]-hydroxy-2-(di-n-propylamino)tetralin binding sites in blood lymphocytes of rats and the modulation by mitogens and immobilization [J].
Sempere, T ;
Cedeño, N ;
Urbina, M ;
Lima, L .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 138 (1-2) :8-16
[24]   MODIFICATION OF BEHAVIORAL-EFFECTS OF 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN FOLLOWING CHRONIC ETHANOL-CONSUMPTION IN THE RAT - EVIDENCE FOR THE INVOLVEMENT OF 5-HT1A RECEPTORS IN ETHANOL DEPENDENCE [J].
KLEVEN, M ;
YBEMA, C ;
CARILLA, E ;
HAMON, M ;
KOEK, W .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (03) :219-228
[25]   (-)-5-methyl-8-hydroxy-(di-n-propylamino)tetralin:: A new 5-HT1A receptor antagonist [J].
Trillat, AC ;
Mathé-Allainmat, M ;
Brémont, B ;
Malagié, I ;
Jacquot, C ;
Gardier, AM ;
Langlois, M .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (06) :437-444
[26]   RECEPTOR-GENES CROSS-TALK: EFFECT OF CHRONIC 5-HT1A AGONIST 8-HYDROXY-2-(DI-N-PROPYLAMINO) TETRALIN TREATMENT ON THE EXPRESSION OF KEY GENES IN BRAIN SEROTONIN SYSTEM AND ON BEHAVIOR [J].
Popova, N. K. ;
Naumenko, V. S. ;
Cybko, A. S. ;
Bazovkina, D. V. .
NEUROSCIENCE, 2010, 169 (01) :229-235
[27]   Development of chiral high performance liquid chromatographic assays for the enantiomers of 8-hydroxy-(di-n-propylamino)tetralin and three 8-keto-pyrrole-substituted analogues [J].
Wood, SA ;
Pegg, SN ;
Simmonds, RJ ;
Stevenson, D .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1996, 14 (11) :1591-1599
[28]   Effects of the dopamine D3 receptor agonist 7-hydroxy-2-(di-N-propylamino) tetralin in hyperthyroidism-induced premature ejaculation rat model [J].
Cinar, O. ;
Durmus, N. ;
Aslan, G. ;
Demir, O. ;
Evcim, A. S. ;
Gidener, S. ;
Esen, A. A. .
ANDROLOGIA, 2018, 50 (04)
[29]   In vivo effects of the putative cognitive enhancer KA-72.HCl in comparison with 8-hydroxy-2-(Di-N-propylamino)tetralin and haloperidol on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions [J].
Teismann, P ;
Ferger, B .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2000, 24 (02) :337-348
[30]   CHRONIC TREATMENT WITH META-CHLOROPHENYLPIPERAZINE (META-CPP) ALTERS BEHAVIORAL AND CEREBRAL METABOLIC RESPONSES TO THE SEROTONIN AGONISTS META-CPP AND QUIPAZINE BUT NOT 8-HYDROXY-2(DI-N-PROPYLAMINO)TETRALIN [J].
FREO, U ;
HOLLOWAY, HW ;
GREIG, NH ;
SONCRANT, TT .
PSYCHOPHARMACOLOGY, 1992, 107 (01) :30-38